Search
for
Sort by
Research 361–390 of 614
- JAK inhibitors in dermatology: The promise of a new drug class
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- A Systematic Scoping Review and Conceptual Analysis of New-Onset Fibromyalgia Manifestations After Non-Hospitalized COVID-19: Empirics, Definitions, Methodologies, Pathophysiology, Mapping of Literature, and Knowledge Gaps
- Stem-cell therapy in dermatology – Challenges and opportunities
- Cutaneous Manifestations in Diabetes
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Progress in Pluronic F127 Derivatives for Application in Wound Healing and Repair
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Flavonoids and saponins: What have we got or missed?
- Design, synthesis, and biological activity of TLR7-based compounds for chemotherapy-induced alopecia
- Review of systemic methotrexate therapy in pediatric dermatoses
- Cepharanthine inhibits enterovirus entry by endolysosomal deacidification and exhibits protective activity <i>in vivo</i>
- IL-1 Receptor–Knockout Mice Develop Epidermal Cysts and Show an Altered Innate Immune Response after Exposure to UVB Radiation
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- A Hairy Cituation – PADIs in Regeneration and Alopecia
- Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata
- Abstracts
- Predictive factors for therapeutic response and cluster analysis in syndrome of undifferentiated recurrent fever (SURF)
- Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature
- Sebaceous gland abnormalities in fatty acyl CoA reductase 2 (Far2) null mice result in primary cicatricial alopecia
- 74398 Oral Intake of Colostrum-Derived Bioactives for Hair and Skin: Integrating Mechanistic, Translational, and Clinical Evidence
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- JAK Inhibitors for Treatment of Alopecia Areata
- Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications
- Emerging role of ILK and ELMO2 in the integration of adhesion and migration pathways
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Alopecia Areata Occurring after COVID-19 Vaccination: A Single-Center, Cross-Sectional Study
- Reversible hair loss in a patient with cicatricial alopecia: A case of regrowth associated with pioglitazone use
- Acne Vulgaris